Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The majority of US adult cancer patients today are diagnosed and treated outside the context of any clinical trial (that is, in the real world). Although these patients are not part of a research study, their clinical data are still recorded. Indeed, data captured in electronic health records form an ever-growing, rich digital repository of longitudinal patient experiences, treatments, and outcomes. Likewise, genomic data from tumor molecular profiling are increasingly guiding oncology care. Linking real-world clinical and genomic data, as well as information from other co-occurring data sets, could create study populations that provide generalizable evidence for precision medicine interventions. However, the infrastructure required to link, ensure quality, and rapidly learn from such composite data is complex. We outline the challenges and describe a novel approach to building a real-world clinico-genomic database of patients with cancer. This work represents a case study in how data collected during routine patient care can inform precision medicine efforts for the population at large. We suggest that health policies can promote innovation by defining appropriate uses of real-world evidence, establishing data standards, and incentivizing data sharing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Toward a Shared Vision for Cancer Genomic Data
Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607591 · Cited by 1,680
Griffith, M., Spies, N. C., Krysiak, K., McMichael, J. F., Coffman, A. C., Danos, A. M., Ainscough, B. J., Ramirez, C. A., Rieke, D. T., Kujan, L., et al. (2017) · Nature Genetics · doi:10.1038/ng.3774 · Cited by 628
Blumenschein, G. R., Smit, E. F., Planchard, D., Kim, D.-W., Cadranel, J., De Pas, T., Dunphy, F., Udud, K., Ahn, M.-J., Hanna, N. H., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv072 · Cited by 349
Prognostic and Predictive Value in KRAS in Non–Small-Cell Lung Cancer: A Review
Wood, K., Hensing, T., Malik, R., & Salgia, R. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0405 · Cited by 164
Opportunities and Challenges in Leveraging Electronic Health Record Data in Oncology
Berger, M. L., Curtis, M. D., Smith, G., Harnett, J., & Abernethy, A. P. (2016) · Future Oncology · doi:10.2217/fon-2015-0043 · Cited by 98
Self-citationKline, R. M., Muldoon, L. D., Schumacher, H. K., Strawbridge, L. M., York, A. W., Mortimer, L. K., Falb, A. F., Cox, K. J., Bazell, C., Lukens, E. W., et al. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.015834 · Cited by 61
Cited by
Precision Medicine: From Science To Value
Ginsburg, G. S., & Phillips, K. A. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1624 · Cited by 759
Singal, G., Miller, P. G., Agarwala, V., Li, G., Kaushik, G., Backenroth, D., Gossai, A., Frampton, G. M., Torres, A. Z., Lehnert, E. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.3241 · Cited by 549
Self-citationArtificial Intelligence and Personalized Medicine
Schork, N. J. (2019) · Cancer Treatment and Research · doi:10.1007/978-3-030-16391-4_11 · Cited by 488
Integrating multi-omics data with EHR for precision medicine using advanced artificial intelligence
Tong, L., Shi, W., Isgut, M., Zhong, Y., Lais, P., Gloster, L., Sun, J., Swain, A., Giuste, F., & Wang, M. D. (2024) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2023.3324264 · Cited by 130
Beyond Randomized Clinical Trials: Use of External Controls
Schmidli, H., Häring, D. A., Thomas, M., Cassidy, A., Weber, S., & Bretz, F. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1723 · Cited by 125
Metadata
- Authors
- Agarwala, V., Khozin, S., Singal, G., O’Connell, C., Kuk, D., Li, G., Gossai, A., Miller, V., & Abernethy, A. P.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2018-05
- Volume
- 37
- Issue
- 5
- Pages
- 765-772
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2800286951
- Cited by
- 104
- References
- 7
- FWCI
- 15.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.